MIRA PHARMACEUTICALS, INC. financial data

Symbol
MIRA on Nasdaq
Location
Miami, FL
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1047% % 80%
Debt-to-equity 10% % -49%
Return On Equity -337% % 23%
Return On Assets -214% % 24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41,876,087 shares 153%
Common Stock, Shares, Outstanding 39,511,492 shares 143%
Entity Public Float $2,440,211,000,000 USD
Common Stock, Value, Issued $3,951 USD 143%
Weighted Average Number of Shares Outstanding, Basic 19,274,947 shares 28%
Weighted Average Number of Shares Outstanding, Diluted 19,274,947 shares 28%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,084,681 USD -26%
General and Administrative Expense $5,021,404 USD -14%
Nonoperating Income (Expense) $179,312 USD 375%
Net Income (Loss) Attributable to Parent $6,858,860 USD 39%
Earnings Per Share, Basic -1 USD/shares -89%
Earnings Per Share, Diluted -1 USD/shares -89%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,641,539 USD
Assets, Current $7,597,841 USD 80%
Operating Lease, Right-of-Use Asset $1,273 USD
Assets $7,633,280 USD 79%
Accounts Payable, Current $83,926 USD
Accrued Liabilities, Current $5,500 USD
Liabilities, Current $83,926 USD -88%
Liabilities $83,926 USD -88%
Retained Earnings (Accumulated Deficit) $33,596,885 USD -26%
Stockholders' Equity Attributable to Parent $7,549,354 USD 111%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3,573,738 USD -56%
Liabilities and Equity $7,633,280 USD 79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,630,027 USD -55%
Net Cash Provided by (Used in) Financing Activities $24,335 USD -103%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 39,511,492 shares 143%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,626,646 USD -51%
Deferred Tax Assets, Valuation Allowance $6,925,163 USD 92%
Deferred Tax Assets, Gross $6,925,163 USD 92%
Operating Lease, Liability $1,273 USD
Operating Lease, Liability, Current $1,273 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards $4,555,400 USD 87%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Operating Lease, Payments $3,819 USD -99%
Additional Paid in Capital $41,142,288 USD 36%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $136,674 USD -104%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%